stars 1 stars 2 stars 3

Kanaph Therapeutics is a drug discovery and pre-clinical stage biotech based in Korea, with a large and small molecule two-track strategy for the development of first-in-class and best-in-class therapeutics in immuno-oncology, targeted therapy and autoimmune (ophthalmology) diseases. Our oncology pipeline includes bi-specific antibodies and small molecules that have a greatly enhanced immuno-stimulatory activity in the tumor micro-environment (TME) for efficient tumor eradication. Our autoimmune disease pipeline is composed of bispecific Fc-fusions that inhibit the alternative complement pathway while inhibiting angiogenesis and downstream complement activation as well.

View Top Employees from Kanaph Therapeutics
Website http://www.kanaphtx.com
Employees 15 (9 on RocketReach)
Founded 2019
Technologies
JavaScript, HTML, PHP +5 more (view full list)
Category Pharmaceutical Manufacturing, Drug Discovery, Biotechnology

Kanaph Therapeutics Questions

Youngsook Shin is the Executive Vice President of Kanaph Therapeutics.

9 people are employed at Kanaph Therapeutics.

Top Kanaph Therapeutics Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users